RPg Family Wealth Advisory’s AstraZeneca AZN Stock Holding History

RPg Family Wealth Advisory’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-640	Closed	-$44.8K	–	232
2018 Q1	$44.8K	Hold	640	–	–	0.04%	128
2017 Q4	$44.4K	Hold	640	–	–	0.04%	136
2017 Q3	$43.4K	Hold	640	–	–	0.04%	146
2017 Q2	$43.6K	Hold	640	–	–	0.04%	173
2017 Q1	$39.9K	Buy	640 +430	+205%	+$25K	0.03%	151
2016 Q4	$11.5K	Sell	210 -131	-38%	-$7.44K	0.01%	247
2016 Q3	$22.4K	Buy	+341	New	+$22.3K	0.02%	166

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

RPg Family Wealth Advisory's AZN Position: Q2 2018 in Review

RPg Family Wealth Advisory sold out of AstraZeneca (AZN) in Q2 2018, closing a stake of 640 shares — an estimated $44.8K sold.

RPg Family Wealth Advisory first reported a position in AZN in Q3 2016 and held it in 7 quarters. The position peaked at $44.8K in Q1 2018. 530 funds tracked by Wall St. Rank hold AZN as of Q2 2018.

RPg Family Wealth Advisory reported no remaining AstraZeneca position as of Q2 2018 after selling out during the quarter.
RPg Family Wealth Advisory sold 640 AstraZeneca shares in Q2 2018, an estimated $44.8K.
RPg Family Wealth Advisory first reported a position in AstraZeneca in Q3 2016 and held it in 7 quarters.
RPg Family Wealth Advisory's AstraZeneca position peaked at $44.8K in Q1 2018.
530 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2018.

Based on RPg Family Wealth Advisory's 13F filing for Q2 2018, filed 10 Aug 2018.